St. Gallen

The recommendations by the expert group, which met in Switzerland in March and involves healthcare leaders from around the world, could impact the reimbursement and adoption of breast cancer genetic tests, such as Agendia's MammaPrint and Genomic Health's Oncotype DX.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.